3 completed, 3 not yet recruiting. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow GLP1 receptor agonist: new trials by email Literature Review of GLP1 receptor agonist trials Research Report on GLP1 receptor agonist
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GLP1 Analogues and the Risk of Osteoarthritis GLP-1 analog, SGLT2 inhibitor, Antidiabetic - Osteoarthritis | Not yet recruiting | Beni-Suef University | 390 | 2026-02-01 | 2026-01-22 | |
| Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy Bariatric Surgery, GLP1 receptor agonist - Lower Urinary Tract Symptoms, Stress Urinary Incontinence | Not yet recruiting | Hartford HealthCare | 200 | 2025-10-01 | 2025-09-16 | |
| Impact of GLP-1 Receptor Agonists on Patients With IPMN GLP1 receptor agonist - IPMN, IPMN, Pancreatic | Not yet recruiting | Hôpital Fribourgeois | 30 | 2025-05-31 | 2025-06-11 | |
| Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease Metformin, Sulfonylurea, DPP-4 inhibitor - Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic | Completed | Weill Medical College of Cornell University | 4888 | 2019-08-01 | 2023-11-09 | |
| A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey INSULIN GLARGINE (U300), metformin, sulfonylurea - Type 2 Diabetes Mellitus | Phase 4 | Completed | Sanofi | 112 | 2016-11-30 | 2019-01-14 |
| Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy? GLP1 receptor agonist, basal insulin, SGLT2 inhibitor - Type 2 Diabetes Mellitus | Not applicable | Completed | University of California, San Francisco | 22 | 2016-08-01 | 2020-11-10 |
Diabetes Mellitus, Type 2 (3) · Fecal Incontinence (1) · Lower Urinary Tract Symptoms (1) · Osteoarthritis (1) · Pancreatic Intraductal Neoplasms (1) · Pelvic Organ Prolapse (1) · Renal Insufficiency, Chronic (1) · Urinary Bladder, Overactive (1) · Urinary Incontinence, Stress (1) · Urinary Incontinence, Urge (1) · Weight Loss (1)
Beni-Suef University (1) · Hartford HealthCare (1) · Hôpital Fribourgeois (1) · Sanofi (1) · University of California, San Francisco (1) · Weill Medical College of Cornell University (1)
United States (3) · Switzerland (1) · Turkey (Türkiye) (1)
Alvin Mushlin (1) · Asmaa Elsayed (1)